Fig. 3From: Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardshipTotal antibacterial use among patients with viral pneumonia according to empiric antibacterial therapy groups and mixed infection. DOT/1000PD days of therapy normalized per 1000 patient-daysBack to article page